ifenprodil has been researched along with cp 101,606 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawker, DD; Jansen Labby, K; Mataka, JJ; Silverman, RB; Trippier, PC | 1 |
| Bordner, J; Butler, TW; Chambers, LK; Chenard, BL; Collins, MA; De Costa, DL; Ducat, MF; Dumont, ML; Fox, CB; Mena, EE | 1 |
| McIntosh, TK; Okiyama, K; Smith, DH; White, WF | 1 |
| Aizenman, E; Brimecombe, JC; Gallagher, MJ; Lynch, DR | 1 |
| Dingledine, R; Doherty, JJ; Fendley, MJ; Lyuboslavsky, P; Mott, DD; Traynelis, SF; Washburn, MS; Zhang, S | 1 |
| Chenard, BL; Menniti, FS | 1 |
| Boyce, S; Hill, RG; Mason, G; O'Donnell, R; Rigby, M; Rupniak, NM; Sirinathsinghji, D; Webb, JK; Wyatt, A | 1 |
| Arai, T; Haradahira, T; Hojo, J; Kida, T; Maeda, J; Maeda, M; Okauchi, T; Sasaki, S; Suhara, T; Suzuki, K; Yamamoto, F; Zhang, MR | 1 |
| Boros, A; Dezso, P; Kolok, S; Nagy, J; Szombathelyi, Z | 1 |
| Bristow, LJ; Clarke, HF; Grimwood, S; Guscott, MR; Hutson, PH; Murray, F | 1 |
| Chazot, PL | 1 |
| Haradahira, T; Kurosaki, F; Maeda, J; Maeda, M; Okauchi, T; Sasaki, S; Suhara, T; Suzuki, K; Yamamoto, F | 1 |
| Hashimoto, K; Hattori, K; Iyo, M; Yanahashi, S; Yuasa, S | 1 |
| Shuaib, A; Wang, CX | 1 |
| Gogas, KR | 1 |
| Barone, I; Bernardi, G; Bonsi, P; Calabresi, P; Centonze, D; Di Luca, M; Gardoni, F; Gubellini, P; Picconi, B; Pisani, A; Tortiglione, A | 1 |
| Albin, RL; Benton, K; Janiszewska, A; Ruprecht, L; Tallaksen-Greene, SJ | 1 |
| Hansen, KB; Ogden, KK; Traynelis, SF; Yuan, H | 1 |
| Itzhak, Y; Liddie, S | 1 |
| DePoy, LM; Gourley, SL; Marvar, PJ; Zimmermann, KS | 1 |
5 review(s) available for ifenprodil and cp 101,606
| Article | Year |
|---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate | 2013 |
Antagonists selective for NMDA receptors containing the NR2B subunit.
Topics: Excitatory Amino Acid Antagonists; Piperidines; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Substrate Specificity | 1999 |
The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies.
Topics: Animals; Binding Sites; Central Nervous System Diseases; Cognition; Drug Delivery Systems; Humans; Neuroprotective Agents; Phenols; Phosphorylation; Piperidines; Protein Subunits; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2004 |
NMDA/NR2B selective antagonists in the treatment of ischemic brain injury.
Topics: Animals; Brain; Brain Ischemia; Conotoxins; Drug Design; Excitatory Amino Acid Antagonists; Felbamate; Glutamic Acid; Humans; Neuroprotective Agents; Phenylcarbamates; Piperidines; Propylene Glycols; Protein Conformation; Rats; Receptors, N-Methyl-D-Aspartate | 2005 |
Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Topics: Animals; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Huntington Disease; Pain; Phenols; Piperidines; Protein Conformation; Receptors, N-Methyl-D-Aspartate | 2006 |
15 other study(ies) available for ifenprodil and cp 101,606
| Article | Year |
|---|---|
(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses.
Topics: Animals; Cell Death; Cells, Cultured; Genes, fos; Hippocampus; Male; Mice; N-Methylaspartate; Nerve Degeneration; Piperidines; Rats; Structure-Activity Relationship | 1995 |
Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat.
Topics: Animals; Behavior, Animal; Body Temperature; Brain Edema; Brain Injuries; Cardiovascular Physiological Phenomena; Cognition; Excitatory Amino Acid Antagonists; Male; Maze Learning; Memory; Motor Activity; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1998 |
An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors.
Topics: Animals; Arginine; CHO Cells; Cricetinae; Dizocilpine Maleate; Dopamine Antagonists; Electrophysiology; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Iodine Radioisotopes; Piperidines; Point Mutation; Receptors, N-Methyl-D-Aspartate | 1998 |
Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition.
Topics: Animals; Excitatory Amino Acid Antagonists; Female; Hydrogen-Ion Concentration; Neuroprotective Agents; Oocytes; Piperidines; Protons; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Xenopus laevis | 1998 |
Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.
Topics: Acetates; Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Lamotrigine; Male; Motor Activity; Pain Measurement; Phenols; Piperidines; Pyrrolidinones; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Triazines | 1999 |
Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (+/-)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors.
Topics: Animals; Brain; Carbon Radioisotopes; Isotope Labeling; Macaca; Male; Metals; Mice; Piperidines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reproducibility of Results; Sensitivity and Specificity; Spermine; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Differential alterations in the expression of NMDA receptor subunits following chronic ethanol treatment in primary cultures of rat cortical and hippocampal neurones.
Topics: Animals; Animals, Newborn; Cells, Cultured; Cerebral Cortex; Culture Media, Serum-Free; Dizocilpine Maleate; Ethanol; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Hippocampus; Kynurenic Acid; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Piperidines; Protein Subunits; Rats; Receptors, N-Methyl-D-Aspartate; RNA Splicing | 2003 |
The effect of (+/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze.
Topics: Administration, Oral; Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hippocampus; Injections, Intraperitoneal; Male; Maze Learning; Memory; Piperidines; Radioligand Assay; Rats; Receptors, N-Methyl-D-Aspartate; Swimming | 2003 |
Synthesis of 11C-labelled bis(phenylalkyl)amines and their in vitro and in vivo binding properties in rodent and monkey brains.
Topics: Amines; Animals; Binding Sites; Brain; Butylamines; Carbon Radioisotopes; In Vitro Techniques; Injections, Intravenous; Isotope Labeling; Macaca mulatta; Male; Mice; Piperidines; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spermine; Tissue Distribution | 2004 |
Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Catalepsy; Cell Count; Corpus Striatum; Dizocilpine Maleate; Dopamine Antagonists; Drug Interactions; Ethylenediamines; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Haloperidol; Immunohistochemistry; Male; Mice; Mice, Inbred Strains; Piperidines; Prazosin; Prosencephalon; Proto-Oncogene Proteins c-fos; Reaction Time; Receptors, N-Methyl-D-Aspartate; Time Factors | 2004 |
NR2B subunit exerts a critical role in postischemic synaptic plasticity.
Topics: Animals; Brain Damage, Chronic; Cerebral Infarction; Cerebrovascular Circulation; Corpus Striatum; Down-Regulation; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Long-Term Potentiation; Male; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2006 |
Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Female; Huntington Disease; Kaplan-Meier Estimate; Male; Mice; Motor Activity; Organ Size; Phenols; Piperidines; Receptors, N-Methyl-D-Aspartate; Sex Factors; Treatment Outcome | 2010 |
Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
Topics: Animals; Dimerization; Excitatory Amino Acid Antagonists; Glutamic Acid; HEK293 Cells; Humans; Oocytes; Patch-Clamp Techniques; Piperidines; Protein Binding; Rats; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Sulfonamides; Trace Elements; Xenopus laevis; Zinc | 2014 |
Variations in the stimulus salience of cocaine reward influences drug-associated contextual memory.
Topics: Aminoacetonitrile; Animals; Cocaine; Conditioning, Operant; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Male; Memory; Mice, Inbred C57BL; Nitric Oxide Synthase Type I; Piperidines; Receptors, N-Methyl-D-Aspartate; Reward | 2016 |
Induction and Blockade of Adolescent Cocaine-Induced Habits.
Topics: Animals; Cocaine; Conditioning, Operant; Decision Making; Dendritic Spines; Drug-Seeking Behavior; Goals; Habits; Imatinib Mesylate; Male; Mice; Mice, Inbred C57BL; Piperidines; Prefrontal Cortex; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule | 2017 |